Harrow Health Inc (NASDAQ:HROW)
| 9.32 BATS BZX Real-Time Price As of 1:55pm ET |  -0.07 / -0.75%Today’s Change | 5.13 Today|||52-Week Range 12.99 | +35.86% Year-to-Date |
Latest HROW News | Press Releases
| Why Seasoned Investors are Retaining Select Medical (SEM) Stock 11:54am / Zacks.com - Paid Partner Content | Why Seasoned Investors are Retaining Acadia (ACHC) Stock Nov 30 / Zacks.com - Paid Partner Content |
| Acadia (ACHC) & Orlando Health Form JV, Boosts Presence Dec 02 / Zacks.com - Paid Partner Content | Harrow (HROW) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? Nov 29 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 9.39 |
| Today’s open | 9.15 |
| Day’s range | 9.05 - 9.49 |
| Volume | 1,300 |
| Average volume (3 months) | 121,842 |
| Market cap | $261.5M |
Data as of 1:55pm ET, 12/06/2021
Growth & Valuation
| Earnings growth (last year) | -2,063.64% |
| Earnings growth (this year) | -105.13% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -4.48% |
| P/E ratio | NM |
| Price/Sales | 3.63 |
| Price/Book | 9.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| XERSXeris Biopharma Hold... | -0.01 | -0.49% |
| BDSIBioDelivery Sciences... | +0.01 | +0.39% |
| VRCAVerrica Pharmaceutic... | +0.68 | +7.34% |
| ---- |
Data as of 1:53pm ET, 12/06/2021
Financials
| Next reporting date | March 23, 2022 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $48.9M |
| Annual profit (last year) | -$3.4M |
| Net profit margin | -6.87% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Nashville, Tennessee |
Forecasts
